PTP4A2 and breast carcinoma: Other study showed that PTP4A2 overexpression promotes breast cancer progression likely via the ERK1/2 pathway, and PTP4A2 may acted as a regulator of RabGGT II activity, this phosphatase might also have a relationship with Rab-regulated recycling pathway that contribute to cell transformation and migration [19].